\-\ Texto\\:\\ \ \(0\)\
\-\ negative\\ for\\ focal\\ neurological\\ findings\ \(0\)\
\-\ negative\\ eeg\ \(0\)\
\-\ vp\\ shunt\ \(0\)\
\-\ chemotherapy\ \(327\)\
\-\ patient\\ died\\ 4\\ months\\ after\\ presentation\ \(0\)\
\-\ \\â\\€\\¢\\ large\\ frond\\-like\\ intraventicular\\ mass\\,\\ right\\ trigone\ \(0\)\
\-\ \\â\\€\\¢\\ marked\\ hydrodrocephalus\ \(0\)\
\-\ \\â\\€\\¢\\ mass\\ enhances\\ homogeneously\\ with\\ contrast\ \(0\)\
\-\ \\â\\€\\¢\\ dandy\\-walker\\ variant\ \(0\)\
\-\ atypical\\ teratoid\\/rhabdoid\\ tumor\ \(1\)\
\-\ \\â\\€\\¢\\ choroid\\ plexus\\ papilloma\ \(4\)\
\-\ \\â\\€\\¢\\ choroid\\ plexus\\ carcinoma\ \(1\)\
\-\ \\â\\€\\¢\\ ependymoma\ \(8\)\
\-\ \\â\\€\\¢\\ pnet\ \(0\)\
\-\ \\â\\€\\¢\\ at\\-rt\\ \\(atypical\\ teratoid\\/rhabdoid\\ tumor\\)\ \(0\)\
\-\ 4\\ month\\ old\\ girl\\ brought\\ to\\ er\\ with\\ projectile\\ vomiting\\.\\ evaluated\\ for\\ gastroenteritis\\.\\ \\ returned\\ to\\ er\\ 1\\ week\\ later\\ with\\ dehydration\\ and\\ seizure\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ choroid\\:\\ 0\\.23233572264766975\ \(0\)\
\-\ plexus\\:\\ 0\\.22334932219911713\ \(0\)\
\-\ atypical\\:\\ 0\\.2032429243059247\ \(0\)\
\-\ hydrodrocephalus\\:\\ 0\\.19809184958691733\ \(0\)\
\-\ er\\:\\ 0\\.1852946080849962\ \(0\)\
\-\ intraventicular\\:\\ 0\\.18304043699636502\ \(0\)\
\-\ trigone\\:\\ 0\\.15744641721326091\ \(0\)\
\-\ negative\\:\\ 0\\.1533716263782863\ \(0\)\
\-\ vp\\:\\ 0\\.1503800005091019\ \(0\)\
\-\ eeg\\:\\ 0\\.14809213923462017\ \(0\)\
\-\ gastroenteritis\\:\\ 0\\.14703268041855508\ \(0\)\
\-\ dehydration\\:\\ 0\\.14703268041855508\ \(0\)\
\-\ projectile\\:\\ 0\\.1423950046227086\ \(0\)\
\-\ pnet\\:\\ 0\\.13304072664406785\ \(0\)\
\-\ died\\:\\ 0\\.1300058522073773\ \(0\)\
\-\ tumor\\:\\ 0\\.12958026975614786\ \(0\)\
\-\ homogeneously\\:\\ 0\\.12908168727635264\ \(0\)\
\-\ brought\\:\\ 0\\.12216659242709738\ \(0\)\
\-\ shunt\\:\\ 0\\.11745312389006983\ \(0\)\
\-\ returned\\:\\ 0\\.11641889993832383\ \(0\)\
\-\ papilloma\\:\\ 0\\.11358253514690357\ \(0\)\
\-\ variant\\:\\ 0\\.10992096068163791\ \(0\)\
\-\ enhances\\:\\ 0\\.10918480210516011\ \(0\)\
\-\ evaluated\\:\\ 0\\.1058374820146133\ \(0\)\
\-\ ependymoma\\:\\ 0\\.1046308050190422\ \(0\)\
\-\ seizure\\:\\ 0\\.10307404359106717\ \(0\)\
\-\ neurological\\:\\ 0\\.10174957224905216\ \(0\)\
\-\ mass\\:\\ 0\\.09462851543629137\ \(0\)\
\-\ marked\\:\\ 0\\.09368564997571106\ \(0\)\
\-\ vomiting\\:\\ 0\\.09165635194951563\ \(0\)\
\-\ later\\:\\ 0\\.08864605941698166\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.08795445324183035\ \(0\)\
\-\ girl\\:\\ 0\\.08689175319905532\ \(0\)\
\-\ presentation\\:\\ 0\\.08526864285827279\ \(0\)\
\-\ week\\:\\ 0\\.0833141594945306\ \(0\)\
\-\ month\\:\\ 0\\.07535031762666634\ \(0\)\
\-\ for\\:\\ 0\\.07508686190062171\ \(0\)\
\-\ focal\\:\\ 0\\.07409222076737385\ \(0\)\
\-\ carcinoma\\:\\ 0\\.07409222076737385\ \(0\)\
\-\ with\\:\\ 0\\.07276469110105864\ \(0\)\
\-\ months\\:\\ 0\\.07210117976052133\ \(0\)\
\-\ large\\:\\ 0\\.06206400157634313\ \(0\)\
\-\ to\\:\\ 0\\.06193349819121293\ \(0\)\
\-\ findings\\:\\ 0\\.06113381138759993\ \(0\)\
\-\ contrast\\:\\ 0\\.06018491738169814\ \(0\)\
\-\ after\\:\\ 0\\.06009038262941577\ \(0\)\
\-\ right\\:\\ 0\\.04106735707594874\ \(0\)\
\-\ patient\\:\\ 0\\.040288032210505635\ \(0\)\
\-\ old\\:\\ 0\\.03665993685454172\ \(0\)\
\-\ and\\:\\ 0\\.025595799415732753\ \(0\)\
